Jones Cecilia
Chief Financial Officer
Jones Cecilia has filed 4 SEC Form 4 filings (14 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Apr 6, 2026.
On the most recent filing, Jones Cecilia is listed as Chief Financial Officer at AGIOS PHARMACEUTICALS, INC. Inside the rolling window, Jones Cecilia reported no open-market purchases and 3 open-market sales totaling $334K in AGIO. The largest disclosed transaction in the window is a sale of 5,035 AGIO shares on Mar 2, 2026, worth $146K.
Companies traded
Other insiders at AGIO
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$334K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 26, 2025 | AGIO | Sale | $134K |
Frequently asked questions
How many SEC Form 4 filings has Jones Cecilia made?
Jones Cecilia has filed 4 SEC Form 4 filings (14 transaction rows) across 1 company since 2025.
Which companies does Jones Cecilia trade?
Jones Cecilia has filed SEC Form 4 disclosures for 1 company, including AGIO.
When was Jones Cecilia's most recent SEC Form 4 filing?
Jones Cecilia's most recent SEC Form 4 filing on Tracefour is dated Apr 6, 2026.
What is Jones Cecilia's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Jones Cecilia is listed as Chief Financial Officer.
What is Jones Cecilia's total buy and sell value in the current window?
Inside the rolling retention window, Jones Cecilia bought $0 and sold $334K based on SEC Form 4 filings.
What was Jones Cecilia's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,035 AGIO shares on 2026-03-02, worth $146K, per SEC Form 4 filings.